About the IRB office and IRB staff
EVMS currently has three internal IRB's. The "1st Thursday" IRB and the "3rd Tuesday" IRB both oversee Biomedical research. The "4th Friday" IRB began meeting in February 2013 and oversees Social Behavioral research. (Social Behavioral research that was previously reviewed by one of the Biomedical IRBs will slowly be transitioned to the new Social Behavioral IRB and PI's will be notified when the change occurs.) Each IRB holds their convened meetings on their respective meeting dates (noted by the name of the Board) each month at 8:30 a.m. Protocols requiring convened Board review are assigned to meetings on a first come, first served basis after the submission is verified as complete by the ORSP/IRB office.
In addition to the convened meetings, the IRB's have sub-committee meetings that are held on the same meeting dates. The sub-committee reviews exempt and expedited studies. Requests for "Not Research" and "Not Human Subject Research" determinations are made by the ORSP/IRB staff who may consult with IRB members as needed.
Chesapeake Research Review, Inc.
EVMS has also designated the Chesapeake Research Review, Inc. (CRRI) as a third IRB for investigators to use for review of studies involving human subjects. EVMS IRB administration will determine a protocol may be submitted to the CRRI. Contact the EVMS IRB office for more information regarding the use of CRRI.
NCI Central IRB's
EVMS has also designated the Adult Oncology and Pediatric Oncology NCI Central IRB's as an for oncology investigators to use for review of certain oncology groups studies. An EVMS IRB chair makes the decision about whether or not to defer review for such protocols. Contact the EVMS IRB office for more information regarding the use of the NCI CIRB.
EVMS ORSP staff
Many of the EVMS ORSP staff are Certified IRB Professionals (CIP). Certification is overseen by a national leader in research ethics, Public Responsibility in Medicine and Research (PRIMR). Staff members also have varying backgrounds, including pharmaceutical regulatory management, post-graduate degree in science, graduate degree in public health, administration of a research unit in clinical practice, and over 40 years of direct IRB experience.
Oversight of the office is provided by the Associate Dean for Research Subjects' Protections.